RESTECH srl and VIVISOL has established a long-term commercial partnership to commercialize the RESMON PRO DIARY and its innovative algorithm for the detection of the risk of exacerbation in COPD patients. Thanks to this collaboration RESTECH will be able to consolidate its operative know-how and bring the latest innovations in home monitoring directly in the homes of COPD patients of the main countries of Europe.

You can read the official press release here (in italian).